Soluble programmed death-1 (sPD-1) and programmed death ligand 1 (sPD-L1) as potential biomarkers for the diagnosis and prognosis of glioma patients

BACKGROUND: This study aimed at investigating the feasibility of testing for soluble programmed death-1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in serum samples of glioma patients and to evaluate the diagnostic and prognostic value of these two soluble molecules. METHODS: Serum sample...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shujun, Zhu, Yadi, Zhang, Chenxi, Liu, Jiajia, Lv, Hong, Zhang, Guojun, Kang, Xixiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Medical Biochemists of Serbia, Belgrade 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710378/
https://www.ncbi.nlm.nih.gov/pubmed/33312060
http://dx.doi.org/10.5937/jomb0-24692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710378/
https://www.ncbi.nlm.nih.gov/pubmed/33312060
http://dx.doi.org/10.5937/jomb0-24692

Ejemplares similares